The Breast Friends Podcast
Activehealthfitnessmedicine

The Breast Friends Podcast

by Dr. Jason Mouabbi and Dr. Paolo Tarantino

Insights from recent episode analysis

Audience Interest

Podcast Focus

Categories: health · fitness
+1 more

Publishing Consistency

Frequency: Irregular
4 episodes since 2026

Platform Reach

Insights are generated by CastFox AI using publicly available data, episode content, and proprietary models.

Medium Confidence

Est. Listeners

N/A

Based on iTunes & Spotify (publisher stats).

  • Per-Episode Audience

    Est. listeners per new episode within ~30 days

    1 - 1,000
  • Monthly Reach

    Unique listeners across all episodes (30 days)

    1 - 5,000
  • Active Followers

    Loyal subscribers who consistently listen

    1 - 500

Market Insights

This ShowCategory Avg
No category insights available.
📡

Platform Distribution

Reach across major podcast platforms, updated hourly

Total Followers

Total Plays

Total Reviews

YouTube

YouTube

Subscribers

Views

Videos

Castbox

Castbox

Followers

Plays

Reviews

Podcast App

Podcast App

Followers

Plays

Reviews

Podcast Republic

Podcast Republic

Followers

Plays

Reviews

TuneIn

TuneIn

Followers

Plays

Reviews

* Data sourced directly from platform APIs and aggregated hourly across all major podcast directories.

On the show

Recent episodes

The Breast Friends Podcast Ep. 4 | The Future of Breast Cancer Treatment

Apr 20, 2026

Unknown duration

The Breast Friends Podcast Ep. 3 | Breast Cancer Trial Madness

Mar 19, 2026

Unknown duration

The Breast Friends Podcast Ep. 2 | The 2026 Breast Oncology Forecast

Feb 17, 2026

Unknown duration

The Breast Friends Podcast Ep. 1 | Breaking the Status Quo: New Frontiers in Breast Cancer Care

Jan 20, 2026

Unknown duration

Introducing The Breast Friends Podcast | Where Breast Cancer Science Meets Real Talk

Jan 20, 2026

Unknown duration

🔗

Social Links & Contact

Official channels & resources

🌐

Official Website

Login

📡

RSS Feed

Login

Chart Positions

4 placements across 4 markets.